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Background: Excess extracellular volume is a major clinical problem in patients with chronic kidney disease (CKD).
However, whether the extracellular volume status is associated with disease progression is unclear. We investigated
the association between the extracellular volume status and renal outcomes.
Methods: We performed a retrospective cohort study of 149 patients with CKD who underwent bioelectrical
impedance analysis (BIA) from 2005 to 2009. Patients were categorized according to tertiles of extracellular volume
status. The extracellular volume status was assessed by examining the ratio of extracellular water measured by BIA
(ECWBIA) to the total body water calculated using the Watson formula (TBWWatson). The main outcomes were
adverse renal outcomes as defined by a decline of ≥50% from the baseline glomerular filtration rate or initiation of
renal replacement therapy.
Results: A higher %ECWBIA/TBWWatson ratio tended to be associated with older age, male sex, diabetes mellitus,
resistant hypertension, lower renal function, lower serum albumin levels, higher proteinuria levels, and a higher
frequency of furosemide use. In the multivariate analysis, proteinuria remained independently associated with the %
ECWBIA/TBWWatson ratio. Both the intracellular and extracellular water volumes decreased with age (correlation
between ICW and age, r = −0.30, P < 0.001; correlation between ECW and age, r = −0.17, P = 0.03). Consequently,
the %ECWBIA in the body fluid composition increased with age. During a median follow-up of 4.9 years, patients in
the highest tertile of the %ECWBIA/TBWWatson ratio were at greater risk of adverse renal outcomes (16.6 per 100.0
patient years) than were those in the lowest tertile (8.1 per 100.0 patient years) or second tertile (5.6 per 100.0
patient years) (log-rank P = 0.005). After adjustment for covariates, the %ECWBIA/TBWWatson ratio was significantly
associated with adverse renal outcomes (hazard ratio, 1.21; 95 % confidence interval, 1.10–1.34; P < 0.001).
Conclusions: The ECWBIA/TBWWatson ratio was independently associated with adverse renal outcomes. Proteinuria
was independently associated with the extracellular volume status. The balance between ICW and ECW changes
with age in that the percentage of ECW content in the body fluid composition increases. Elderly patients with CKD
may thus be susceptible to volume overload.
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Excess extracellular volume is a major clinical problem
in patients with chronic kidney disease (CKD) and causes
lower extremity edema, hypertension, pulmonary vascular
congestion or edema, and heart failure [1]. However,
whether excess extracellular volume is associated with kid-
ney disease progression is unclear, and such studies are
hampered by the lack of suitable markers of hypervolemia.
In bioimpedance analysis (BIA), the ratio of extracellular
water (ECW) to total body water (TBW) has been used as
an indicator of the fluid volume status [2-6]. However, the
ECW/TBW ratio may not be an ideal measurement of
volume overload. The ECW/TBW ratio is affected not
only by changes in the ECW, but also by changes in the
intracellular water (ICW) component of TBW. The
amount of ICW decreases with aging [7]. Therefore, an in-
creased ECW/TBW ratio may be also observed in lean,
elderly patients without edema. Using the Body Compos-
ition Monitor, which assesses the extracellular volume sta-
tus by comparing the measured ECW to the expected
ECW, Tsai et al. recently reported an association between
fluid overload and adverse kidney outcomes in the short
term in patients with advanced stage 4 to 5 CKD [8].
Anthropometric formulas combined with tracer dilution
techniques have been extensively used to calculate TBW
in patients with CKD. The Watson formula, which is rou-
tinely used to calculate the efficiency of dialysis, was ori-
ginally derived from pooled data of healthy subjects and
provides information about adequate fluid volume ad-
justed for age and sex [9]. We hypothesized that the ratio
of the ECW as measured by BIA (ECWBIA) to the TBW as
calculated using the Watson formula (TBWWatson) might
also be used to assess the extracellular fluid status in clin-
ical practice. In addition, we assessed the extracellular vol-
ume status using the ratio of the measured ECW to the
expected ECW as calculated by an equation described by
Peters et al. based on healthy potential renal transplant
donors [10].
The goals of the present study were to (1) identify fac-
tors associated with the extracellular volume status, (2)
investigate the relationship between the extracellular
volume status and renal outcomes in patients with CKD
and n study the prognostic performance of parameters
associated with the extracellular volume status in pre-
dicting adverse renal outcomes.
Methods
Study design
This study was approved by the Ethics Committee of
Toho University Omori Medical Center, Tokyo, Japan
(approval number: 25–252) and was performed in ad-
herence with the Declaration of Helsinki. Informed con-
sent was obtained from all participants. Of 170 patients
with CKD aged ≥20 years with BIA body compositionmeasurements obtained from August 2005 to January
2009, 149 patients with complete clinical data in whom
we could assess anthropometric measurements, blood
pressure, proteinuria, and kidney function at the same
time were studied.
The following patient characteristics and parameters
were examined: age, sex, height, body weight, body mass
index (BMI), underlying renal disease, office blood pres-
sure, serum albumin level, total cholesterol level, trigly-
ceride level, fasting blood glucose level, uric acid level,
serum creatinine (Cr) level, estimated glomerular filtra-
tion rate (eGFR), urinary protein to creatinine ratio in a
random urine sample (UPCR), and use of diuretics and
antihypertensive agents. In total, 127 of the 147 patients
were able to provide a 24-hour urine sample. Hyperurice-
mia was diagnosed if the uric acid level was >7.0 mg/dL
for men and >5.7 mg/dL for women in accordance with
previously performed population surveys [11]. The eGFR
was calculated according to the CKD-Epidemiology Col-
laboration equation [12]. Resistant hypertension was de-
fined as uncontrolled blood pressure (office systolic blood
pressure of ≥130 mmHg or office diastolic blood pressure
of ≥80 mmHg) despite antihypertensive therapy using
three or more medications, including diuretics. Controlled
blood pressure using four or more drugs was also defined
as resistant hypertension [13,14]. Patients were followed
up until August 2013 (median, 1789 days; 10th–90th per-
centile, 422–2689 days) unless loss to follow-up or death
occurred.
Adverse outcomes
Cox proportional hazards models with time-dependent
covariates were used to compare renal outcomes and all-
cause mortality. The endpoint of the study was the time
to the first record of either one of the following adverse
events: ≥50% decline in the GFR relative to baseline or
initiation of either dialysis therapy or renal transplant-
ation [15,16].
Assessment of body fluid status
BIA was performed in a standard manner with the pa-
tient lying supine on a flat, nonconductive bed for at
least 15 min. A segmental BIA instrument (Inbody S20®;
Biospace Co., Ltd., Seoul, Korea [www.biospaceamerica.
com]) with eight tactile electrodes was used. The
microprocessor-controlled switches and BIA analyzer
were activated, and segmental resistances of the arms,
trunk, and legs were measured at four frequencies (5,
50, 250, and 500 kHz). Thus, 20 segmental resistances
were measured for each patient. Using the BIA software,
the sum of the segmental resistances for each body seg-
ment was used to calculate the TBW, ICW, and ECW.
Each measured fluid compartment was expressed as
both the actual value and percentage of the body weight.
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formula (ECWPeters): (−2.47 × 0.842 + 8.76 × body surface
area) for men and (−1.96 × 0.572 + 8.05 × body surface
area) for women [10]. We also estimated the TBW accord-
ing to the Watson formula (TBWWatson): (2.447 +
[0.0956 × age] + [0.1074 × height] + [0.3362 × body weight])
for men and (−2.097 + [0.1069 × height] + [0.3362 × body
weight]) for women [9]. The body surface area was esti-
mated using the equation described by Haycock et al. [17].
The ratio of ECWBIA to ECWPeters or the percentage of
ECWBIA to TBWWatson were modified as indicators of ex-
cess fluid volume [7].
Statistical analyses
Data were statistically analyzed using JMP 9.0 software
(SAS Institute, Inc., Cary, NC, USA). Patients were classi-
fied into tertiles according to their extracellular volume
status. Because all parameters used to assess the extracel-
lular volume status had different actual values and per-
centages between men and women, we divided the tertile
values by men and women and combined tertiles 1, 2, and
3 in men and women, respectively. Each measured value
was expressed as either mean ± standard deviation or per-
centage. Statistical significance was assessed using a linear
regression model to compare the mean values of possible
risk factors among the tertile groups [18] and were checked
by one-way analysis of variance for continuous variables
and Pearson’s chi-squared test for categorical variables. We
constructed Bland–Altman and residual plots of TBWBIA
and TBWWatson to assess bias. Correlations between vari-
ables were examined using Pearson’s product–moment
correlation coefficient. Logistic and linear regression ana-
lyses were used to analyze the association between the %
ECWBIA/TBWWatson ratio and demographic factors. Ex-
planatory variables that were significantly correlated (P <
0.1) with the %ECWBIA/TBWWatson ratio were then sub-
jected to multivariate analysis to identify independent as-
sociations. Kaplan–Meier survival curves for adverse renal
outcomes were generated. A Cox regression model with
time-dependent covariates was used to analyze the rela-
tionship between the %ECWBIA/TBWWatson ratio and ad-
verse renal outcomes, and analyzed values were expressed
as hazard ratios (HRs) with corresponding 95% confidence
intervals (CIs). Receiver operating characteristic curve
analysis was used to identify the best prognostic factor for
adverse renal outcomes. A probability (P) value of <0.05
was considered to be statistically significant.
Results
Comparison between percentage of ECW in body weight,
ratio of ECWBIA to ECWPeters, and percentage of ECWBIA to
TBWWatson
We compared three parameters of extracellular volume
status assessment: (%ECWBIA in body weight, ECWBIA/ECWPeters ratio, and %ECWBIA/TBWWatson ratio). As
shown in Figure 1, patients with a higher %ECWBIA were
more likely to have a lower body weight. The %ECWBIA
in body weight was negatively correlated with body
weight regardless of the actual extracellular volume sta-
tus. On the other hand, patients in a higher tertile with re-
spect to the other two parameters were more likely to have
both higher actual values and higher extracellular volume
percentages. We also observed preliminarily correlations
between these three parameters and the patients’ main
demographic characteristics (Additional file 1: Table S1).
The %ECWBIA in body weight was higher among patients
with lower body weights and was only correlated with the
serum albumin level. The ECWBIA/ECWPeters ratio was
positively correlated with a higher prevalence of resistant
hypertension and furosemide use, lower serum albumin
level, and higher UPCR level; it was also highly dependent
upon height, explaining why height was included in the
equation described by Peters et al. [10]. The %ECWBIA/
TBWWatson ratio exhibited a significant correlation with
most demographic factors among these three parameters.
Interestingly, the ECWBIA/ECWPeters ratio and the %ECW-
BIA/TBWWatson ratio showed different associations with age.
Age tended to increase as the ECWBIA/ECWPeters ratio de-
creased, whereas age tended to increase as the %ECWBIA/
TBWWatson ratio increased. This difference may be ex-
plained by the fact that ECWBIA decreased with age in our
population but that ECWPeters did not decrease with age in
a potential healthy donor population [10]. For the above-
mentioned reasons, we used the %ECWBIA/TBWWatson ratio
as the main parameter of the extracellular volume status.
Correlations between age and an imbalance between
measured ICW and ECW
Correlations between age and an imbalance between the
measured ICW and ECW are presented in Figure 2. Both
the ICW and ECW content decreased with age, although
the trend was predominantly observed in the ICW content
(correlation between ICW and age, r = −0.30, P = 0.001;
correlation between ECW and age, r = −0.18, P = 0.03).
Thus, the percentage of measured ECWBIA in TBWBIA had
a moderately positive correlation with age (r = 0.60, P <
0.001).
Relationship between measured TBWBIA and estimated
TBWWatson by sex
The mean differences between the measured TBWBIA
and estimated TBWWatson for men and women were
0.41 L (95% CI, −0.19 to 1.01; P = 0.17) and −0.75 L
(95% CI, −1.27 to −0.23; P = 0.01), respectively (Additional
file 2: Figure S1A and C). Residual plots showed that bias
in the measured TBWBIA and estimated TBWWatson were
greatest at higher measured TBWBIA values for both sexes
(Additional file 2: Figure S1B and D).
Figure 1 Associations between extracellular volume status and actual values of body composition (A in men and B in women) and
percentages of fluid volume in body weight (C in men and D in women). Abbreviations: BW, body weight; ECWBIA, extracellular water as
measured by electrical bioimpedance analysis; ECWPeters, extracellular water calculated using the Peters formula; TBWWatson, total body water
calculated using the Watson formula.
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The characteristics of the 149 patients according to the
tertiles of the %ECWBIA/TBWWatson ratio are listed in
Table 1. The tertile values were 38.3% and 41.1% in men
and 37.0% and 39.4% in women. Of the 149 patients, 80
were men and 69 were women, with a mean age of 63.7
± 16.1 years; 24 patients (16.1%) had diabetes mellitus.
The mean eGFR was 63.8 ± 50.1 ml/min per 1.73 m2. Pa-
tients with a higher %ECWBIA/TBWWatson ratio tended
to have diabetes mellitus, resistant hypertension, a lower
diastolic blood pressure, a higher pulse pressure, a
higher serum creatinine level, a lower eGFR, a lower
serum albumin level, a higher UPCR level, and a higher
prevalence of furosemide use (P < 0.05). In contrast, there
were no significant differences in the 24-hour urinary so-
dium excretion rate among the three groups. Patients in
the lowest tertile were more likely to have a higher BMI
than were those in the higher tertiles (24.0 ± 4.2 kg/m2 in
the lowest tertile vs. 22.0 ± 3.5 kg/m2 in the second tertile
and 21.6 ± 2.9 kg/m2 in the highest tertile, P = 0.001). Not-
ably, patients in the higher tertiles of the %ECWBIA/
TBWWatson ratio were more likely to have a higher percent
body weight of TBW, ICW, and ECW.Independent factors associated with extracellular
volume status
Age, male sex, diabetes mellitus, the eGFR, and the UPCR
level were correlated with the %ECWBIA/TBWWatson ratio
in univariate analysis. In the multivariate analysis, male
sex and UPCR remained independently associated with
the %ECWBIA/TBWWatson ratio (Table 2).
Correlation between serum albumin and extracellular
volume status
As shown in Additional file 3: Figure S2 (online), the serum
albumin level was weakly correlated with the %ECWBIA in
body weight (r = −0.32, P < 0.001) and ECWBIA/ECWPeters
ratio (r= −0.24, P = 0.004) and was moderately correlated
with the %ECWBIA/TBWWatson ratio (r= −0.44, P < 0.001).
Correlations of %ECWBIA/TBWWatson with renal outcome
and all-cause mortality
During the follow-up period, 52 patients had adverse
renal outcomes (8.5 per 100.0 patient years) and 25 had
all-cause death (4.6 per 100.0 patient years). The
Kaplan–Meier analysis curves revealed significant differ-
ences in renal outcomes among the different %ECWBIA/
Figure 2 Correlations between age with an imbalance between ICW and ECW. Abbreviations: ICWBIA, intracellular water; ECWBIA, extracellular
water; TBWBIA, total body water as measured by bioimpedance analysis.
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tile were at greater risk of disease progression (16.6 per
100.0 patient years) than were those in the lowest (8.1
per 100.0 patient years) and second tertiles (5.6 per
100.0 patient years) (P = 0.01). After adjustment for covari-
ates including age, sex, diabetes mellitus, systolic blood
pressure, UPCR level, and baseline eGFR, the %ECWBIA/
TBWWatson ratio was found to be significantly associated
with adverse renal outcomes (HR, 1.21; 95% CI, 1.10–1.34;
P < 0.001) (Table 3). As shown in Additional file 4: Figure
S3 (online), we also depicted the Kaplan–Meier analysis
curves for renal outcomes among the different tertiles of
%ECWBIA in body weight and ECWBIA/ECWPeters ratio.
Patients in the highest %ECWBIA/ECWPeters tertile exhib-
ited significantly lower renal survival than did the other
two groups. In contrast, no significant differences were
noted in renal survival according to the different tertiles of
%ECWBIA in body weight or tertiles 1 or 2 of %ECWBIA/
ECWPeters (P = 0.10).
Prognostic performance of %ECWBIA/TBWWatson ratio in
predicting adverse renal outcomes
We constructed receiver operating characteristic curves
to determine the cut-off of the %ECWBIA/TBWWatson ra-
tio that best predicts adverse renal outcomes. The opti-
mal cut-off values for all patients, male patients, andfemale patients were 39.9%, 42.2%, and 40.0%, respect-
ively. Using these cut-off values, the respective areas
under the curve were 0.655 (95% CI, 0.552–0.746), 0.665
(95% CI, 0.527–0.780), and 0.620 (95% CI, 0.453–0.763)
(Figure 4).
Discussion
This study revealed that the ECWBIA/TBWWatson ratio
reflects the extracellular volume status and is associated
with adverse renal outcomes in patients with CKD. Add-
itionally, our findings showed that the %ECWBIA/
TBWWatson ratio is influenced by sex and proteinuria. Fi-
nally, age affected the balance between the ICW and
ECW and increased the percentage of ECW in the body
fluid composition.
BIA methods are used to noninvasively measure the
ECW, ICW, and TBW and calculate the free fat mass
and fat based on empirical equations [19]. However, the
measure of free fat mass is influenced by the TBW con-
tent because the fat free mass is obtained by dividing the
TBW by 0.733. The ECWBIA/TBWBIA ratio increases
along with ECW excess and decreased ICW. Therefore,
the ECWBIA/TBWBIA ratio appears to be an inadequate
marker of the volume status [7]. In fact, the present find-
ings show that the percentage of ECWBIA in TBWBIA was
positively correlated with age. Two recent studies used a
Table 1 Patients characteristics separated by tertiles of the percentage of ECWBIA to TBWWatson
Population characteristics Percentage of ECWBIA to TBWWatson P for
ANOVATertile 1 (n = 50) (27 men
with <38.3% and 23
women with <37.0%)
Tertile 2 (n = 49) (26 men
with 38.3%–41.0% and 23
women with 37.0%–39.4%)
Tertile 3 (n = 50) (27 men
with ≥41.1% and 23
women with ≥39.5%)
Age, years 62.0 ± 16.6 61.8 ± 15.1 67.1 ± 16.4 0.18
Height, cm 159 ± 10 159 ± 11 161 ± 8 0.46
Weight, kg 61 ± 15 56 ± 12 56 ± 10 0.09
Body surface area, m2 1.62 ± 0.21 1.56 ± 0.21 1.58 ± 0.16 0.41
Body mass index, kg/m2 24.0 ± 4.2 22.0 ± 3.5 21.6 ± 2.9 <0.01
Underlying disease
Glomerulonephritis, n (%) 23 (46.0) 22 (45.0) 17 (34.0) 0.41
Diabetes mellitus, n (%) 4 (8.0) 7 (14.3) 13 (26.0) <0.05
Nephrosclerosis, n (%) 9 (18.0) 10 (20.4) 9 (18.0) 0.94
ADPKD, n (%) 0 (0.0) 0 (0.0) 1 (2.0) 0.37
Others, n (%) 14 (28.0) 10 (20.4) 10 (20.0) 0.56
Systolic blood pressure, mmHg 127 ± 19 122 ± 17 129 ± 21 0.19
Diastolic blood pressure, mmHg 75 ± 11 71 ± 9 69 ± 10 <0.01
Pulse pressure, mmHg 52 ± 11 51 ± 13 60 ± 17 <0.01
Resistant high blood pressure, n (%) 6 (12.0) 12 (24.5) 19 (38.0) <0.05
TBWBIA, L (% in BW) 30.1 ± 7.5 30.9 ± 7.2 32.7 ± 5.6 0.14
(49.6 ± 5.6) (55.3 ± 5.6) (58.7 ± 5.1) (<0.001)
ICWBIA, L (% in BW) 18.4 ± 4.7 18.8 ± 4.6 19.7 ± 3.4 0.30
(30.2 ± 3.5) (33.5 ± 3.8) (35.2 ± 3.2) (<0.001)
ECWBIA, L (% in BW) 11.7 ± 2.8 12.1 ± 2.6 13.1 ± 2.2 0.02
(19.3 ± 2.1) (21.7 ± 2.0) (23.4 ± 2.1) (<0.001)
Serum creatinine, mg/dL 1.67 ± 1.17 1.76 ± 1.27 2.55 ± 1.78 <0.01
eGFRCKD-EPI, ml/min per 1.73 m
2 71.7 ± 48.8 71.0 ± 52.7 48.9 ± 46.2 <0.05
Serum albumin, g/dL 4.1 ± 0.4 4.0 ± 0.4 3.7 ± 0.5 <0.001
Total cholesterol, mg/dL 200 ± 34 193 ± 36 191 ± 55 0.53
Triglycerides, mg/dL 147 ± 71 139 ± 95 129 ± 88 0.55
Fasting blood glucose, mg/dL 103 ± 19 132 ± 45 134 ± 42 <0.05
UPCR, g/g · Cr 0.9 ± 1.5 0.8 ± 1.3 1.6 ± 1.9 <0.05
Uric acid, >7.0 mg/dL in men
or >6.0 mg/dL in women, n (%)
23 (46.9) 27 (55.1) 32 (64.0) 0.23
24-hour urinary urea nitrogen excretion, g/day 2.1 ± 1.0 2.5 ± 1.9 2.2 ± 1.5 0.40
24-hour urinary creatinine excretion, g/day 1.5 ± 1.1 1.6 ± 1.5 1.5 ± 0.8 0.81
24-hour urinary sodium excretion, mmol/day 143 ± 58 128 ± 50 130 ± 54 0.37
Furosemide, n (%) 5 (10.0) 6 (12.2) 18 (36.0) <0.01
Other diuretics, n (%) 7 (14.0) 7 (14.3) 6 (12.0) 0.94
ACE inhibitors, n (%) 14 (28.0) 17 (34.7) 16 (32.0) 0.77
AT1-R blockers, n (%) 30 (60.0) 28 (57.1) 25 (50.0) 0.58
Other antihypertensives 20 (40.0) 25 (51.0) 31 (62.0) 0.09
Abbreviations: TBWBIA total body water as measured by bioimpedance analysis, ICWBIA intracellular water as measured by bioimpedance analysis, ECWBIA extracellular
water as measured by bioimpedance analysis, TBWWatson total body water calculated using the Watson formula, eGFRCKD-EPI estimated glomerular filtration rate using the
Chronic Kidney Disease Epidemiology Collaboration equation, UPCR urinary protein-to-creatinine ratio, ACE inhibitors angiotensin-converting enzyme inhibitors,
AT1-receptor blockers angiotensin II type 1 receptor blockers.
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Table 2 Independent factors associated with the percentage of ECWBIA to TBWWatson
Variables Univariate analysis Multivariate analysis*
ß (95% CI) P-value ß (95% CI) P-value
Age, per 10 years of age 0.18 (0.04–0.72) 0.03 0.01 (−0.40–0.44) 0.94
Men 0.21 (0.17–1.27) 0.01 0.18 (0.04–1.16) 0.04
Diabetes mellitus 0.30 (0.67–2.13) <0.001 0.11 (−0.31–1.31) 0.23
eGFRCKD-EPI, ml/min per 1.73 m
2 −0.24 (−5.71 to −1.11) 0.01 −0.05 (−0.02–0.01) 0.63
UPCR, g/g · Cr 0.32 (0.33–0.96) <0.001 0.17 (0.20–0.87) 0.01
Note: *Significant factors associated with the percentage of extracellular water volume as measured by bioimpedance analysis to total body water volume
calculated by the Watson formula identified in the univariate analysis (P < 0.10) were subjected to multivariable analysis. When the eGFR calculated by the revised
formula for Japanese patients based on the Modification of Diet in Renal Disease method was used as the dependent variable instead of eGFRCKD-EPI, the results
remained similar (data not shown). Additionally, when the serum albumin level was used as the dependent variable instead of UPCR, the independent factors
were sex, diabetes mellitus, and serum albumin (data not shown).
Abbreviations: ECWBIA extracellular water as measured by bioimpedance analysis, TBWWatson total body water calculated using the Watson formula, eGFRCKD-EPI
estimated glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration equation, UPCR urinary protein-to-creatinine ratio, β standardized
regression coefficient, CI confidence interval.
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vice quantified fluid overload using reference values de-
rived from the pooled data of healthy subjects [21]. We
preliminarily used the expected ECW as calculated by the
Peters formula and the expected TBW as calculated by
the Watson formula as reference values of body fluid
composition. These two parameters were highly correlated
with each other in our study population (r = 0.97 for men
and r = 0.98 for women) (data not shown). Peters et al. re-
ported that the ECW was retained in healthy potential do-
nors of older ages [10]. On the other hand, the Watson
formula includes age in men as a coefficient. The mea-
sured ECWBIA gradually decreased with age in our study.
As a result, elderly patients tended to exhibit a lower
ECWBIA/ECWPeters ratio. The ECWBIA/ECWPeters ratio
may be not a useful maker if the extracellular volume
changes with age only in patients with CKD and not in
healthy subjects. The present findings show that the ratio
of the measured extracellular volume to the estimated
body fluid volume can serve as a useful marker of theFigure 3 Kaplan–Meier survival curves for adverse renal
outcomes by tertiles of %ECWBIA/TBWWatson.volume status in patients with CKD. This result may be
one reason that the %ECWBIA/TBWWatson ratio exhibited
a relative increase in the extracellular volume with respect
to the expected fluid status, resulting in a good balance
between the ICW and ECW for age. Notably, a higher
extracellular volume was associated with adverse renal
outcomes during a relatively long follow-up period (me-
dian duration of 4.9 years) for both of the ECWBIA/
ECWPeters ratio and the %ECWBIA/TBWWatson ratio.
Additionally, the ECWBIA/TBWWatson ratio was associ-
ated with traditional risk factors for kidney disease pro-
gression, including age, male sex, diabetes mellitus,
higher pulse pressure, resistant hypertension, lower
eGFR, lower serum albumin level, and higher protein-
uria level. These findings may suggest that a higher
extracellular volume causes hemodynamic instability. In
contrast, sodium excretion was not associated with fluid
excess. Whether sodium intake and sodium retention
have a one-to-one relationship and whether sodium in-
take is linearly associated with the development of end-
stage renal disease remain unclear [22-24]. Younger
subjects and those without uremia consume a higher
variety of foods with various levels of sodium, protein,
and total calories than do elderly people and patients
with uremia. These biases may have hampered studies
in this area.
Proteinuria was a strong factor in the development of
a higher extracellular volume. Hypoalbuminemia, mostly
in association with massive proteinuria, produces an in-
creased interstitial fluid volume and a contracted intra-
vascular volume contraction by a diminished oncotic
pressure gradient, thus inducing renal sodium retention
by activation of the renin-angiotensin-aldosterone sys-
tem [25]. In addition, differences in all parameters of the
extracellular volume status were found between men
and women; specifically, it the extracellular volume was
lower in women. The ECW and ICW contents are gen-
erally lower in women than in men because women have
Table 3 Hazard ratios of different clinical variables for adverse renal outcomes
Variables Univariate analysis Multivariate analysis*
HR (95% CI) P-value HR (95% CI) P-value
Age, per 10 years of age 1.03 (1.01–1.05) 0.01 0.84 (0.69–1.04) 0.10
Men 1.82 (1.04–3.29) 0.04 1.13 (0.60–2.10) 0.70
Diabetes mellitus 3.60 (1.90–6.50) <0.001 1.49 (0.72–2.98) 0.28
%ECWBIA/TBWWatson 1.24 (1.13–1.35) <0.001 1.21 (1.10–1.34) <0.001
Systolic blood pressure, mmHg 1.02 (1.01–1.04) <0.001 1.00 (0.99–1.02) 0.63
Baseline eGFRCKD-EPI, ml/min/1.73 m
2 0.92 (0.90–0.94) <0.001 0.96 (0.95–0.98) <0.001
UPCR, g/gCr 1.29 (1.15–1.42) <0.001 1.20 (1.01–1.38) 0.04
Note: *Adjusted for age, male sex, diabetes mellitus, systolic blood pressure, ECWBIA/TBWWatson percentage, baseline estimated glomerular filtration rate, and urinary
protein–creatinine ratio (variables associated with adverse renal outcomes identified in the univariate analysis [P < 0.10] were entered into the multivariable model).
When the ECWBIA/ECWPeters ratio was used as the dependent variable instead of the %ECWBIA/TBWWatson ratio, the results remained similar (data not shown).
Abbreviations: HR hazard ratio, CI confidence interval, %ECWBIA/TBWWatson percentage of extracellular water as measured by bioimpedance analysis to total body
water calculated using the Watson formula, eGFRCKD-EPI estimated glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration equation,
UPCR urinary protein-to-creatinine ratio.
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http://www.biomedcentral.com/1471-2369/15/189a relatively higher proportion of fat. Otherwise, differences
between these two parameters may be caused by inaccur-
acies in the determination of the measured fluid content
and estimated fluid content. Our findings revealed a differ-
ence between the measured TBWBIA and estimated
TBWWatson in both men and women (Additional file 2:
Figure S1). In both sexes, these differences increased with
increases in the measured TBWBIA (Additional file 2:Figure 4 Receiver operating characteristic curves in the assessment o
outcomes in all patients, male patients, and female patients. Abbrevia
TBWWatson, total body water calculated using the Watson formula; AUC, areFigure S1B and D). Thus, differences between the actual
values and reference values may contribute to the fluid
volume status. The Watson formula was designed to esti-
mate the TBW of healthy Caucasian subjects; however, it
must be interpreted with caution because it may overesti-
mate the TBWWatson in Japanese patients, especially
women. A previous study reported differences in the TBW
among individuals of different races [26].f %ECWBIA/TBWWatson as a prognostic factor of adverse renal
tions: TBWBIA, total body water as measured by bioimpedance analysis;
a under the curve; CI, confidence interval.
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http://www.biomedcentral.com/1471-2369/15/189Aging cells are known to shrink and undergo apop-
tosis [27-29]. Fluid imbalance in patients with CKD is
characterized by excess ECW associated with sodium re-
tention [30,31] and decreased ICW associated with mal-
nutrition [32]. In fact, patients with CKD with a leaner
body mass have a higher prevalence of hypertension,
poorer control of hypertension, and greater incidence of
left ventricular hypertrophy. This phenomenon is known
as the “obesity paradox” [33,34]. Our findings highlight
the notion that elderly patients with CKD may be more
susceptible to volume overload because the reduced
intracellular volume caused by aging and malnutrition
lessens the capacity of cells to retain fluid. This strongly
supports the hypothesis that a lower serum albumin
level is significantly correlated with the fluid volume.
The best %ECWBIA/TBWWatson ratio cut-offs for adverse
renal outcomes among male, female, and all patients were
42.2%, 40.0%, and 39.9%, respectively. These values were
close to the ECW/ICW ratio of 2:3. The abovementioned
threshold values may be useful for determining extracellu-
lar volume excess. However, whether removal of excess
fluid improves renal outcomes remains unclear.
This study has several limitations. First, it was a retro-
spective cohort study conducted at a single center. How-
ever, it provided detailed information on patients’ body
fluid composition and had a relatively long follow-up
period. Second, the ECWBIA/TBWWatson ratio may not be
a precise indicator of volume status; the estimated
TBWWatson and actual TBWBIA differ in Japanese patients.
We recognize that this parameter was not compared with
an indicator for congestive heart failure, such as the N-
terminal of the prohormone brain natriuretic peptide. Re-
gardless, the ECWBIA/TBWWatson ratio is associated with
many factors associated with fluid volume overload; BIA
can be used to easily and noninvasively assess the body
fluid composition, and the results correlate with those of
isotopic dilution and dual-energy X-ray absorptiometry
[35]. The estimated TBWWatson is widely used in this area.
We believe that the ECWBIA/TBWWatson ratio is a prac-
tical parameter of the extracellular volume status and that
the reported data will support future studies in this area.Conclusions
In the present study, the ECWBIA/TBWWatson ratio was
associated with adverse renal outcomes during a relatively
long follow-up period. This finding suggests that a higher
extracellular volume has an adverse effect on kidney dis-
ease. Proteinuria is independently associated with the
extracellular volume status. Aging leads to change in the
balance between the ICW content and ECW content and
increases the percentage of the ECW content in the body
fluid composition. Consequently, elderly patients with
CKD may be susceptible to volume overload.Additional files
Additional file 1: Table S1. Correlations between demographic
characteristics and parameters of extracellular volume status.
Additional file 2: Figure S1. Agreement between total body water as
measured by bioimpedance analysis and total body water calculated
using the Watson formula. Abbreviations: TBWBIA, total body water as
measured by bioimpedance analysis; TBWWatson, total body water
calculated using the Watson formula; CI, confidence interval.
Additional file 3: Figure S2. Correlations between serum albumin level
and %ECWBIA in body weight and %ECWBIA/TBWWatson. Abbreviations:
ECWBIA, extracellular water; TBWWatson, total body water calculated using
the Watson formula.
Additional file 4: Figure S3. Kaplan–Meier survival curves for adverse
renal outcomes by (A) tertiles of %ECWBIA in body weight and (B) ratio of
ECWBIA to ECWPeters. Abbreviations: ECWBIA, extracellular water; BW, body
weight; TBWBIA, total body water as measured by bioimpedance analysis;
TBWWatson, total body water calculated using the Watson formula.
Abbreviations
CKD: Chronic kidney disease; ECW: Extracellular water; TBW: Total body water;
ICW: Intracellular water; BIA: Bioimpedance analysis; BMI: Body mass index;
Cr: Serum creatinine; eGFR: Estimated glomerular filtration rate; UPCR: Urinary
protein-to-creatinine ratio; HR: Hazard ratio; CI: Confidence interval.
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